Osteoporosis Flashcards

1
Q

Define osteoporosis.

A

Skeletal disorder characterised by COMPROMISED BONE STRENGTH leading to INCREASED RISK OF FRACTURE caused by DECREASED BONE DENSITY/QUALITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 3 causes of osteoporosis.

A

Menopause
Hyperparathyroidism
Low dietary calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 3 fractures which are especially common in osteoporosis.

A

Colles’ wrist fracture
Vertebral compression fracture
Femoral neck fracture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List 8 risk factors for osteoporotic fractures.

A
Age 65+
Decreased bone mineral density
Previous fracture
Family history
Early menopause
Primary hyperparathyroidism
Long term steroids
Propensity to fall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List 6 complications of osteoporotic fractures.

A
Disability
Death
Kyphosis
Loss of height
Crowding of organs
Back pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which investigations would you do for osteoporosis? (2)

A

DEXA scans

FRAX fracture risk calculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What calculation is done by the DEXA scan to assess bone mineral density?

Define it.

A

t-score

Def.: “Number of standard deviations above or below the mean for a healthy adult population of the same sex and ethnicity as the patient”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you interpret the t-score results of a DEXA scan? (4)

A

Normal: -1.0+
Osteopenia: -1 to -2.5
Osteoporosis: -2.5+

Established osteoporosis: -2.5+ PLUS previous fracture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the main variables which a FRAX calculation takes into account to measure fracture risk? (3)

A

Age
Bone mineral density
Previous fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 main aspects of managing osteoporosis?

A

Decrease risk of falls
Lifestyle changes
Pharmacological treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How would you decrease the risk of falls in osteoporosis? (4)

A

Avoid drugs with sedative effects
Treat sensory deficits (e.g. impaired vision)
Gait and balance training
Occupational therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which lifestyle changes would you recommend in osteoporosis? (4)

A

Adequate dietary calcium
Regular exercise
Smoking cessation
Avoid alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the main pharmacological treatment for osteoporosis?

List 5 other drugs which can be used.

A

Bisphosphonates

OTHER DRUGS:
Calcium/vitamin D
Hormone replacement therapy
Selective oestrogen receptor modulator (SERM)
Teriparatide
Denosumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give 2 examples of bisphosphonates.

Describe their mechanism of action. (2)

A
Alendronic acid (alendronate)
Ibandronate

MECHANISM OF ACTION:

  1. Inhibit osteoclast bone resorption
  2. No effect on osteoblasts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List 5 side effects of bisphosphonates.

A
Dyspepsia
Dysphagia
Abdominal pain
Headache
Acid regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give 1 example of a selective oestrogen receptor modulator (SERM).

A

Raloxifene

17
Q

Describe the mechanism of action of teriparatide. (1)

A
  1. PTH analogue
18
Q

Describe the mechanism of action of denosumab. (1)

A
  1. Monoclonal antibody against RANKL

a. Therefore prevents osteoclast activation

19
Q

Describe the RANK-RANKL system in bone remodelling. (3)

A
  1. Pre-osteoclasts express RANK on their surface
  2. When stimulated, pre-osteoblasts secrete RANKL
  3. RANKL binds to RANK and activates pre-osteoclasts to form active osteoclasts
20
Q

Describe the role of osteoprotegerin in bone remodelling. (3)

A
  1. Secreted by mature osteoblasts
  2. Binds to RANKL (secreted by pre-osteoblasts)
  3. Therefore RANKL can no longer bind to RANK on pre-osteoclasts
    a. Therefore there is no osteoclast activation